Prostate Cancer Clinical Trials in San Francisco

Showing 221-240 of 261 trials

Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer

NCT01229618

Current imaging options do not assess prostate cancer well. This study will combine two magnetic resonance imaging modalities, MRI and MRSI, in order to determine the utility to physicians and patients with prostate cancer in making treatment decisions and seeing how well various types of treatment work. Hyperpolarized pyruvate (13C) is an investigational product that may enhance the imaging capability of MRI and MRSI. Hyperpolarized pyruvate will be injected into the body to determine how it is metabolized and how it's metabolism can be assessed using MR imaging. The purpose of this study is to determine the safety and metabolism of hyperpolarized pyruvate in humans, and how this can be used to increase the effectiveness of MR imaging with regards to patient care.

Prostate Cancer

University of California, San Francisco31 participantsStarted Oct 2010

San Francisco, California, United States

COMPLETEDPhase 2< 1 mile

Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer

NCT00715104

This is an open label, Phase 2 trial of immunotherapy with sipuleucel-T as neoadjuvant treatment in men with localized prostate cancer.

Prostate Cancer

Dendreon42 participantsStarted Jul 2008

Los Angeles, California, United States • San Francisco, California, United States • Portland, Oregon, United States +4 more locations

Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer

Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer

Prostate Cancer Trials in Other Cities

Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy

Sandostatin for Patients With Androgen Independent Prostate Cancer

3-AP in Treating Patients With Advanced Prostate Cancer

An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer

Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men

Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer

A Trial of Degarelix in Patients With Prostate Cancer

The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer

Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With Docetaxel

Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

Other Conditions in San Francisco